← Back to Search

Amino Acid Nutritional Supplement

EAA+LEU vs total AA for Non-Small Cell Lung Cancer

N/A
Waitlist Available
Led By Marielle PK Engelen, PhD
Research Sponsored by Texas A&M University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights

Study Summary

Weight loss commonly occurs in lung cancer patients, negatively influencing their quality of life, treatment response and survival. Gains in lean body mass are difficult to achieve in cancer unless specific metabolic abnormalities are targeted. It is our hypothesis that a nutritional supplement containing a high amount of essential amino acids will target the metabolic alterations of cancer patients. Preliminary research performed in our laboratory in elderly supports this hypothesis. We hypothesize that intake of an essential amino acid nutritional supplement will positively influence protein synthesis rate in advanced non-small cell lung cancer (NSCLC) patients. Furthermore, insight in the underlying mechanism of the higher anabolic response of the essential amino acid supplement will be examined. This information will potentially enable us to formulate a supplement that is more effective than normal food intake, and that will reduce the need for muscle protein breakdown.

Eligible Conditions
  • Non-Small Cell Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acute change in Net whole body protein synthesis rate
Secondary outcome measures
Acute change in Arginine turnover rate
Acute change in Liver protein synthesis rate
Acute change in Urea turnover rate
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Total AA vs EAA+LEUExperimental Treatment1 Intervention
Group II: EAA+LEU vs total AAExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Texas A&M UniversityLead Sponsor
140 Previous Clinical Trials
24,310 Total Patients Enrolled
University of ArkansasOTHER
486 Previous Clinical Trials
150,236 Total Patients Enrolled
Marielle PK Engelen, PhDPrincipal InvestigatorUniversity of Arkansas
2 Previous Clinical Trials
70 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby May 2025